Billable / Specific Code
ICD-10-CM E70.321 is the diagnosis code for Tyrosinase positive oculocutaneous albinism. This code falls under the section "Metabolic disorders" within Chapter 4 — Endocrine, nutritional and metabolic diseases (E00-E89). It is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. Medical coders and healthcare providers use this code to document and classify diagnoses in electronic health records, insurance claims, and clinical databases.
Understanding where E70.321 sits in the ICD-10-CM classification helps ensure proper coding:
Yes, E70.321 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
E70.321 is the ICD-10-CM diagnosis code for "Tyrosinase positive oculocutaneous albinism". It is used by healthcare providers to classify and document this condition in medical records and insurance claims.
The parent code of E70.321 is E70.32 ("Oculocutaneous albinism"). E70.321 provides a more specific classification within this category.
E70.321 is located in Section E70-E88 — "Metabolic disorders" within Chapter 4 of the ICD-10-CM Tabular List.
Use E70.321 when the patients documented diagnosis matches "Tyrosinase positive oculocutaneous albinism" and the clinical documentation supports this level of specificity. Always verify with the latest ICD-10-CM guidelines and payer requirements.
The ICD-10-CM code for Tyrosinase positive oculocutaneous albinism is E70.321.
Yes, E70.321 can be used as a primary diagnosis code since it is billable and specific.
E70.321 is in Chapter 4 of the ICD-10-CM Tabular List.
Yes, E70.321 is a valid ICD-10-CM code for the 2026 fiscal year, subject to official CMS updates.